Table 4.

Cost-effectiveness results (PoMeT vs. TAU).

Perspective	Cost Difference (95% CI) PoMeT vs. TAU	QALY Difference (95% CI) PoMeT vs. TAU	ICER (95% CI) PoMeT vs. TAU	Interpretation of ICER
Health and social care	£270 (−£2191 to £2731)	−0.0177 (−0.0538 to 0.0186)	−£15,254/QALY (−£347,765/QALY to £645,414/QALY)	PoMeT on average is more expensive and less effective
Societal	−£458 (−£3783 to £2868)	−0.0175 (−0.0537 to 0.0186)	£26,171/QALY (−£666,926/QALY to £788,883/QALY)	PoMeT on average is less expensive but less effective

PoMeT: PoMeT intervention group, TAU: Treatment As Usual group, QALYs: Quality-Adjusted Life Years, ICER: Incremental Cost-Effectiveness Ratio.